Use of Proprietary Names by Prescribers for Generic Products

Autor: Vicky Borders-Hemphill, Irene Z Chan, Katelyn Brown, Grace Chai, Briana B. Rider, Kellie Taylor

Publikováno v: Therapeutic Innovation & Regulatory Science. 52:256-260

Proprietary names are often used when prescribing drug products in the United States. The purpose of this study is to describe prescribers' use of proprietary names for generic products, branded-generic names, on prescription orders and to identify p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f41001ea55bf349712262faf897a6bd
https://doi.org/10.1177/2168479017723399

Special Considerations for Proprietary Name Review: Focus on Products That May Be Prescribed 'As Directed'

Autor: Hina Mehta, Briana B. Rider, Lubna Merchant

Publikováno v: Ther Innov Regul Sci

BACKGROUND: Look-alike and sound-alike (LASA) drug name similarity is often cited as a major factor contributing to wrong drug errors. When present on a prescription, differing product characteristics or directions for use may help healthcare profess

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::402c5301380a787e3f40c28e9115acdd
https://pubmed.ncbi.nlm.nih.gov/29929377

Racial and ethnic disparities in health care-associated Clostridium difficile infections in the United States: State of the science

Autor: Aaron R. Ducoffe, Briana B. Rider, Avi Baehr, Sandra Yang, Dale J. Hu

Publikováno v: American journal of infection control. 44(1)

Background Among health care-associated infections (HAIs), Clostridium difficile infections (CDIs) are a major cause of morbidity and mortality in the United States. As national progress toward CDI prevention continues, it will be critical to ensure

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8c76c88e7f5f1079749dc03dc82e7ac
https://pubmed.ncbi.nlm.nih.gov/26454749

Use of Proprietary Names by Prescribers for Generic Products.

Autor: Borders-Hemphill V; Food and Drug Administration, 10903 New Hampshire Ave, Bldg 22 room 4424, Silver Spring, MD, 20993, USA. Vicky.Borders-Hemphill@fda.hhs.gov., Chan IZ; Food and Drug Administration, 10903 New Hampshire Ave, Bldg 22 room 4424, Silver Spring, MD, 20993, USA., Brown K; Purdue University, Indianapolis, IN, USA., Rider B; Food and Drug Administration, 10903 New Hampshire Ave, Bldg 22 room 4424, Silver Spring, MD, 20993, USA., Taylor K; Food and Drug Administration, 10903 New Hampshire Ave, Bldg 22 room 4424, Silver Spring, MD, 20993, USA., Chai G; Food and Drug Administration, 10903 New Hampshire Ave, Bldg 22 room 4424, Silver Spring, MD, 20993, USA.

Publikováno v: Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2018 Mar; Vol. 52 (2), pp. 256-260. Date of Electronic Publication: 2017 Aug 07.